The regulatory profile is unambiguous: BPC-157 is not registered as a drug and since 2022 has been on the WADA list in category S0
If multiple people are using the same vial in a shared lab space, you might also want to add the user's initials for each access
DSIP (delta sleepinducing peptide) is a short, synthetic neuropeptide commonly used in laboratory research to explore sleep-associated signaling and broader neuroendocrine regulation
Some women using these injections have reported experiencing symptoms like irregular bleeding, changes in menstrual flow, and, in some cases, a temporary pause in menstruation
Results showed statistically significant reductions in body weight and body fat percentage in the AOD9604 treatment groups compared to placebo, with the highest dose producing average fat mass reductions of approximately 2.6 kg greater than placebo
Additionally, BPC-157 restores gut barrier integrity, potentially reducing systemic inflammation that drives neuroinflammation linked to depression and anxiety